Many of the latest Israeli innovations and activities are potential “Game changers” that can improve the lives of millions of people. They include treatments for cancer, influenza and breathing problems. They combat terrorism and measles epidemics. They put research satellites into space and power the fastest computers in the world. They re-invent the motor engine, save the bees, water resources and the agriculture of developing countries. They convert enemies into allies and turn darkness into light. Michael Ordman
www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
Extending lives of pancreatic cancer patients. In the latest Phase 2a trial of the pancreatic cancer treatment from Israel’s BioLineRx (see here) three-quarters of the patients at disease stage 4 were able to get their disease under control. The trial combined BL-8040, KEYTRUDA (Pembrolizumab) and chemotherapy.
https://www.jpost.com/HEALTH-SCIENCE/New-Israeli-pancreatic-cancer-treatment-could-extend-most-patients-lives-611085https://ir.biolinerx.com/news-releases/news-release-details/biolinerx-announces-preliminary-phase-2a-data-triple-combination
Molecular checkups to avoid chemotherapy. A 10-year study of 1,365 Israelis indicates that chemotherapy can be avoided for most women who have early diagnosis and biopsy of the most common types of breast cancer. In 97.4% of those passing a Oncotype DX molecular checkup post-surgery, the cancer never returned.
https://www.ynetnews.com/articles/0,7340,L-5625101,00.html
https://www.nature.com/articles/s41523-019-0137-3
Early diagnosis of thyroid cancer. Another molecular diagnostic test has been developed by doctors at Hadassah University Medical Center in Jerusalem. It can early-diagnose thyroid cancer accurately from biopsies of small nodules that often develop on the thyroid. Previous alternatives were inaccurate or expensive.
https://www.jpost.com/Israel-News/Israel-develops-breakthrough-method-to-identify-thyroid-cancer-611102
Phase 3 progress for Universal Flu vaccine. Israel’s BiondVax has 12,400 participants from 83 hospitals in the Phase 3 double-blind placebo-controlled trials of its Universal Flu vaccine. If successful, the new vaccine could reach pharmacies in 2023. BiondVax’s new Jerusalem facility can produce 20-40 million doses per year.
https://www.calcalistech.com/ctech/articles/0,7340,L-3775594,00.html
European award for stem cell investigator. Assistant Professor Yaron Fuchs of Israel’s Technion Institute is one of 27 global scientists to receive a “Young Investigators” award from the European Molecular Biology Organization. Yaron harnesses stem cell apoptosis (cell death due to injury) for driving tissue regeneration.
https://unitedwithisrael.org/young-israeli-professor-harnesses-power-of-stem-cells-to-heal-injuries/
